An update on the treatment options for focal segmental glomerulosclerosis-Reference-Cited by-同舟云学术

An update on the treatment options for focal segmental glomerulosclerosis

Published:2009-03 Issue:4 Volume:10 Page:615-628
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Meyrier Alain

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656560902754029

Reference101 articles.

1. Meyrier A, Niaudet P. Minimal changes and focal-segmental glomerulosclerosis. Third edition. In: Davison AM, Cameron JS, Grünfeld JP, et al, editors, Oxford Textbook of Clinical Nephrology. Vol. 1. Oxford: Oxford University Press, 2005. p. 439-69

2. Mechanisms of Disease: focal segmental glomerulosclerosis

3. Changing incidence of glomerular diseases in adults

4. Is there really an increase in non-minimal change nephrotic syndrome in children?

5. Clinical picture and outcome of primary focal segmental glomerulosclerosis

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of matrix metalloproteinase inhibitor (doxycycline) in the treatment of primary focal segmental glomerulosclerosis;Journal of The Egyptian Society of Nephrology and Transplantation;2024-07

2. The Pursuit of New Treatments for Focal Segmental Glomerulosclerosis: Harmonizing Innovation With the DUET Study of Sparsentan;Kidney Medicine;2024-06

3. The Metabolomics Signature Associated with Responsiveness to Steroid Therapy in Focal Segmental Glomerulosclerosis: A Pilot Study;Revista de investigaci�n Cl�nica;2019-04-17

4. Focal Segmental Glomerulosclerosis;Clinical Journal of the American Society of Nephrology;2017-02-27

5. Evidence-based clinical practice guidelines for nephrotic syndrome 2014;Clinical and Experimental Nephrology;2016-04-21